Profile
Dr. Michael Spigarelli is a Chief Medical Officer at PsyBio Therapeutics Corp.
Dr. Spigarelli was previously employed as a Chairman by American Board of Clinical Pharmacology, Inc., a Vice President-Medical Affairs by Immucor, Inc., and a Chief Medical Officer by Lumen Bioscience, Inc. He received his MBA from the University of Utah and a doctorate degree from the University of Michigan.
Michael Spigarelli active positions
| Companies | Position | Start |
|---|---|---|
| PSYBIO THERAPEUTICS CORP. | Chief Tech/Sci/R&D Officer | 05/04/2021 |
Former positions of Michael Spigarelli
| Companies | Position | End |
|---|---|---|
| IMMUCOR, INC. | Chief Tech/Sci/R&D Officer | - |
American Board of Clinical Pharmacology, Inc.
American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services Operates health-related professional association | Chairman | - |
Lumen Bioscience, Inc.
Lumen Bioscience, Inc. BiotechnologyHealth Technology Develops biologic drug platform | Chief Tech/Sci/R&D Officer | - |
Training of Michael Spigarelli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Immucor, Inc.
Immucor, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells transfusion and transplantation diagnostics products | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Board of Clinical Pharmacology, Inc.
American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services Operates health-related professional association | Commercial Services |
Lumen Bioscience, Inc.
Lumen Bioscience, Inc. BiotechnologyHealth Technology Develops biologic drug platform | Health Technology |
PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp. Pharmaceuticals: OtherHealth Technology Develops biosynthetic psychoactive compounds | Health Technology |
- Stock Market
- Insiders
- Michael Spigarelli
















